ArticleOpen medicine (Warsaw, Poland)2022

Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data.

Chengrui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.